Skip to content

Month: December 2017

Exercise and RP (AVAMC and Emory)

Source: ClinicalTrials.gov – Retinitis Pigmentosa – Exercise and RP (AVAMC and Emory) Condition:   Retinitis PigmentosaIntervention:   Other: Spin exerciseSponsor:   Emory UniversityNot yet recruiting Source: ClinicalTrials.gov – Retinitis Pigmentosa – Exercise and RP (AVAMC and Emory)

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

jCyte Reports Results for Phase 1/2a Clinical Trial for Retinal-Cell Treatment

Source: Foundation Fighting Blindness Blog – Eye on the Cure – jCyte Reports Results for Phase 1/2a Clinical Trial for Retinal-Cell Treatment A retinal-cell treatment for people with retinitis pigmentosa (RP) has performed encouragingly in a Phase 1/2a clinical trial. Developed by jCyte, the treatment was evaluated for 12…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

History Is Made: FDA Approves Spark’s Vision-Restoring Gene Therapy

Source: Foundation Fighting Blindness Blog – Eye on the Cure – History Is Made: FDA Approves Spark’s Vision-Restoring Gene Therapy Spark Therapeutics’ vision-restoring RPE65 gene therapy has received marketing approval from the U.S. Food and Drug Administration, becoming the first gene therapy to gain regulatory approval in the U.S.…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Somewhat Positive Press Coverage Somewhat Unlikely to Affect Applied Genetic Technologies (AGTC) Share Price

Source: Google News – Retinitis pigmentosa – Somewhat Positive Press Coverage Somewhat Unlikely to Affect Applied Genetic Technologies (AGTC) Share Price Somewhat Positive Press Coverage Somewhat Unlikely to Affect Applied Genetic Technologies (AGTC) Share Price  The Ledger Gazette Full coverage Source: Google News – Retinitis pigmentosa – Somewhat Positive…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest